About
SynuCa Tx develops disease-modifying treatments for Parkinson's Disease by targeting the SERCA calcium transporter to restore neuronal calcium balance disrupted by pathological α-Synuclein.
Explore SynuCa Tx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.